U.S. payments for Amgen drug criticized at hearing
(Re


Reuters - U.S. government payments for an
anemia drug used to treat kidney dialysis patients encourage
overuse that is wasteful, costly and raises the risk of heart
complications, experts told Congress on Wednesday.